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ABSTRACT: C-telopeptides and related pyridinoline cross-links of bone
Type I collagen are sensitive markers of bone resorption in osteolytic diseases
such as osteoporosis and osteoarthritis. We have studied the release of C-te-
lopeptide pyridinoline crosslinks of Type I collagen as measures of bone de-
struction in periodontal disease. Studies in preclinical animal models and
humans have demonstrated the relationship between radiographic bone loss
and crevicular fluid C-telopeptide levels. We have recently found that C-te-
lopeptide levels correlate strongly with microbial pathogens associated with
periodontitis and around endosseous dental implants. Host-modulation of
bone-related collagen breakdown has been shown by studies in humans dem-
onstrating that MMP inhibition blocks tissue destruction and release of C-te-
lopeptides in patients with active periodontal disease.
 
Periodontal disease is initiated by microbial pathogens that elicit a host immune re-





flicted with periodontitis experience breakdown of alveolar bone, periodontal
ligament, and tooth root cementum. Uncontrolled periodontal tissue destruction
eventually leads to tooth loss. A challenge in periodontology is the accurate and ear-
ly assessment of tissue breakdown in patients with periodontal disease. Current
methods of disease detection lack diagnostic sensitivity and specificity. Periodontal
diagnostic procedures address several important functions, which include: screen-
ing; diagnosis of specific periodontal diseases; identification of sites or subjects at
increased risk of experiencing progression of periodontal destruction; treatment




This paper focuses on the ability of the class of molecules known as the pyridin-
oline cross-links to identify tooth sites or subjects at an increased risk of experienc-
ing periodontal tissue destruction. Research will be reviewed in preclinical and
clinical investigations that illustrate the relationship among pyridinoline cross-links,
periodontal pathogens, and alveolar bone loss. The paper concludes with recent de-
velopments in the inhibition of periodontal tissue destruction by matrix metallopro-
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PYRIDINOLINE CROSS-LINKS: 
BIOCHEMISTRY AND CLINICAL CORRELATIONS
 
Pyridinoline cross-links have emerged as very promising biomarkers of bone re-
sorption in an array of osteolytic diseases. Pyridinoline (hydroxylysl pyridinoline or
Pyr) and deoxypyridinoline (lysyl pyridinoline or Dpy), N-telopeptides, and





 Newly formed collagen fibrils deposited in the extracellular
matrix of bone are stabilized by mature cross-links formed by lysyl oxidase on lysine
and hydroxylysine residues in the N- and C-terminal regions of collagen chains. This
process results in the formation of divalent collagen cross-links that by further con-
densation yield trivalent Pyr and Dpy. 
Osteoclastic bone resorption initiates the release of cross-linked immunoreactive
telopeptides Pyr and Dpy.  Urinary levels of Pyr and Dpy correlate with histological




 as well as by radiopharmaceutical
















 increased levels of Pyr and Dpy are
found in the circulation. In patients with metastatic bone disease, bisphosphanate














 therapy, coincident with increases in spinal
bone mineral density.
 
PYRIDINOLINE CROSS-LINKS AND BONE RESORPTION
IN PERIODONTITIS
 
Given the important contribution of Pyr cross-links in systemic osteolytic diseas-
es, over the past half of a decade researchers have begun to explore the ability of
these molecules to detect bone resorption in the periodontium. The majority of diag-
nostic agents currently target the use of gingival crevicular fluid (GCF), which is an
exudate that can be harvested from the gingival sulcus or periodontal pocket. As









 Therefore, GCF offers great potential as a source for fac-
tors that may be associated with active tissue destruction. Several investigators have
assessed the roles of various connective tissue breakdown products or enzymes in-
volved in bone metabolism from GCF (reviewed in Refs. 13 and 14). However, most
of these molecules are not bone-specific markers of tissue breakdown, and thus are





Host factors in the GCF associated with the anatomic events of periodontitis and
peri-implantitis may be useful as markers for identifying and predicting future dis-
ease progression. A biochemical marker specific for bone degradation may be useful





Recently, several studies have been conducted examining C-telopeptides in GCF.
Talonpoika and Hämäläinen demonstrated strong correlations between C-telopeptide
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levels and clinical parameters of periodontal tissue destruction such as radiographic




 Furthermore, they showed that in a small subset of pa-
tients provided periodontal therapy, dramatic reduction of GCF C-telopeptide levels
resulted as soon as 2 days after treatment. In a ligature-induced experimental peri-
odontitis study in dogs, the GCF levels of pyridinoline cross-links (C-telopeptide and
deoxypyridinoline) significantly increased during the development of attachment loss








. 3). As early as 3 days after the initiation of
experimental disease, tartrate-resistant acid phosphastase (TRAP+) mononuclear and





 The TRAP+ cells related strongly with elevated levels of Dpy in the se-
rum, urine and GCF, suggesting that these markers are sensitive enough to be detected
not only locally in the GCF but also systemically in the circulation. Moreover,
FIGURE 1. Release of pyridinoline cross-links during active alveolar bone resorption
in periodontitis. Periodontitis is initiated by bacterial plaque and endotoxin, which cause a
host immune response with recruitment of inflammatory cells such as neutrophils to the pe-
riodontal lesion. Neutrophils release MMP-8, which causes alveolar bone, periodontal lig-
ament, and cementum destruction. Pyridinoline cross-links such as Dpy and C-telopeptide
are released into the GCF soon after the initiation of osteoclastic bone resorption in peri-
odontitis.
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FIGURE 2. Checkpoints of periodontal disease progression. This diagram demon-
strates examples of pathogens, cytokines, tissue breakdown components, and clinical indi-
ces used to detect stages of active periodontitis. The pathway of pathogenic infection by
bacteria and endotoxin leading to a host inflammatory response results in tissue destruction
as measured by bone-degradative products (e.g., pyridinoline cross-links). The anatomic
event of alveolar bone loss demonstrated on a radiograph or periodontal probing gives the
patient’s diagnosis of periodontitis. Interventions identifying tissue destruction prior to sig-
nificant anatomic events are goals of periodontal diagnostic tests.
FIGURE 3. Crevicular fluid C-telopeptide levels in response to experimental peri-
odontitis in beagles.  Note significant increases in GCF C-telopeptide throughout the entire
disease progression phase following the initiation of periodontal disease by silk ligatures.
Once ligatures were removed, concomitant with scaling and root planing, GCF telopeptide
levels decreased significantly compared to baseline for the first 6 weeks of the disease re-
covery phase followed by another significant increase in C-telopeptide at week 24.  Error
bars represent ± SE from a total of 36 samples/time point. +p < 0.05 compared to control;
φp < 0.05 compared to baseline. (From Giannobile et al.16 Reproduced by permission.)
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C-telopeptide levels in GCF were highly sensitive and specific for predicting future






RELATIONSHIP BETWEEN PERIODONTAL 
PATHOGENS AND C-TELOPEPTIDES
 
Destructive periodontal diseases can be thought of as a series of infections that




 A large body of
literature supports an etiologic role of selected subgingival species such as 
 
Bacteroi-











 These species may promote periodontal tissue destruction, including
bone resorption, by the expression of a multitude of virulence factors. 
Our group has recently demonstrated the relationship between GCF C-telopeptide





 Thirty-six periodontal subjects were evaluated for C-telopeptides in relation
to a panel of subgingival species in subjects exhibiting various clinical presentations
such as health, gingivitis, and periodontitis. Subgingival plaque and GCF samples
were taken from tooth sites in each of 36 subjects. The presence and amounts of 40
subgingival taxa were determined in plaque samples using whole genomic DNA
probes and checkerboard DNA-DNA hybridization, and GCF C-telopeptide levels
were quantified by RIA. Clinical assessments made at the same sites included pocket
depth and attachment level. Relationships between C-telopeptide levels and clinical
parameters as well as subgingival species were determined by regression analysis.
The results demonstrated significant differences among disease categories for GCF














Relationship between prevealence of specific periodontal pathogens and
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 5.7 pg/site). C-telopep-
tide levels related modestly to several clinical parameters. Regression analysis indi-
cated that C-telopeptide levels correlated strongly with mean subject levels of several
periodontal pathogens including 
 



















 1). The data indicate that there is a positive
relationship between C-telopeptides and periodontal pathogens. 
 
RELATIONSHIP BETWEEN PERIODONTAL PATHOGENS WITH 
C-TELOPEPTIDES AT ORAL IMPLANT FIXTURES
 
The treatment of edentulous and partially edentulous individuals with endosseous




However, a small portion of the population experiences peri-implantitis, an inflam-
matory condition characterized by both connective tissue and bone destruction that
can result in dental implant failure. Current methods used to assess peri-implant and
periodontal health include probing and radiography, which present a historical per-
spective, but give no information regarding current disease activity. Oringer and co-
workers recently reported the application of the DNA-DNA hybridization technique
on the enumeration of subgingival organisms associated with endosseous dental im-




 GCF and plaque samples were collected at im-
plant and tooth sites. Radioimmunoassay techniques were utilized to determine GCF
C-telopeptide levels, and plaque samples were analyzed utilizing checkerboard
DNA-DNA hybridization. C-telopeptide levels and subgingival plaque composition
were not significantly different between implants and teeth. Implant sites colonized
by 
 







 exhibited odds ratios of 12.4, 9.3, 8.1, and 6.7,
respectively, of detecting C-telopeptide. These results suggest a relationship be-
tween elevated C-telopeptide levels at implant sites and some subgingival organisms
associated with disease progression. Future studies should examine levels of
C-telopeptide and other putative pyridinoline cross-links at implant fixtures exhibit-
ing clinical signs of failure. Finally, longitudinal studies are necessary to examine
the predictive ability of GCF C-telopeptide to identify the development of peri-im-
plant bone loss.
 
BLOCKING OF PERIODONTAL TISSUE DESTRUCTION 
BY MATRIX METALLOPROTEINASES
 
Studies performed by Golub and co-workers have helped to elucidate the ability
of MMP inhibitors to block tissue destruction in patients with periodontal disease
(reviewed in Refs. 22 and 23). We recently reported results from eighteen patients
with moderate to severe periodontitis entered into an open-labeled study to examine





 At baseline, and at 1- and 2-month appointments, GCF sam-
ples were analyzed for C-telopeptide and osteocalcin by RIA, and collagenolytic en-
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zyme activity and MMP species were studied by Western blotting. The results from
this investigation revealed that C-telopeptide levels decreased nearly 70% after the





. 4). The reductions in GCF C-telopeptide and collagenase levels
were sustained for an additional month. Interestingly, osteocalcin, a marker of bone
turnover did not relate to C-telopeptides and did not predict response to therapy. Lev-
els of matrix metalloproteinases (MMPs) -8 and -13 were decreased concomitant
with C-telopeptide reductions during the 2-month observation period. These data
suggest that MMP inhibitors, such as low-dose doxycycline, may block attachment




Pyridinoline cross-links are important markers of bone resorption in a variety of
bone metabolic diseases including periodontitis. These molecules may become im-
portant indicators of active tissue destruction in the accurate diagnosis of alveolar
FIGURE 4. Doxycycline therapy inhibits collagenolytic breakdown of periodontal tis-
sues. GCF C-telopeptide (by RIA) and collagenase  (by % [3H-methyl] collagen α compo-
nents degraded to αA fragments during incubation with 1.0 mM APMA at 22°C) in GCF of
subjects with severe periodontitis before and during a 2-month regimen of 20 mg b.i.d. dox-
ycycline.  Each value represents the mean levels from 28 sites in 7 subjects. (*p < 0.05 as
compared to baseline.) (From Weinberg and Bral.23 Reproduced by permission.)
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bone loss. Furthermore, the use of blockers of collagen breakdown such as matrix
metalloproteinase inhibitors may prove useful in the control of periodontal tissue de-




The collaborations and discussions with Drs. Sig Socransky, Anne Haffajee, Rich
Oringer, Michael Palys, and Larry Golub are appreciated. These studies have been
supported by grants from the NIH (Grants DE 04881 and DE 11814) and the Institute







































. 1996. Molecular basis and clinical


























nary excretion of pyridinoline crosslinks correlates with bone turnover measured on


































. 1990. Urinary collagen crosslinks are highly correlated with radio-




 Osteoporosis. C. Christiansen &


























, 1993. Evaluation of bone turnover in type I osteoporosis using biochemical





















. 1989. Urinary excretion of
the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis.





















. 1990. Urinary excretion































1995. Type I collagen degradation product (ICTP) gives information about the nature
of bone metastases and has prognostic value in prostate cancer. Br. J. Cancer 71:
1061–1064.
10. GARNERO, P., W.J. SHIH, E. GINEYTS, D.B. KARPF & P.D. DELMAS. 1994. Comparison
of new biochemical markers of bone turnover in late postmenopausal osteoporotic
women in response to alendronate treatment. J. Endocrinol. Metab. 79: 1693-1700.
11. YASUMIZU, T., K. HOSHI, S. IIJIMA & A. ASAKA. 1998. Serum concentration of the
pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a
useful indicator of decline and recovery of bone mineral density in lumbar spine:
analysis in Japanese postmenopausal women with or without hormone replacement.
Endocrine Journal 45: 45–51.
12. CIMASONI, G. 1983. Crevicular Fluid Updated. Karger. Basel.
13. LAMSTER, I.B. 1997. Evaluation of components of gingival crevicular fluid as diagnos-
tic tests. Ann. Periodontol. 2: 123–37.
412 ANNALS NEW YORK ACADEMY OF SCIENCES
14. GIANNOBILE, W.V. 1997. Crevicular fluid biomarkers of oral bone loss. Curr. Opinion
Periodontol. 4: 19–30.
15. TALONPOIKA, J.T. & M.M. HÄMÄLÄINEN. 1994. Type I carboxyterminal telopeptide in
human gingival crevicular fluid in different clinical conditions and after periodontal
treatment. J. Clin. Periodontol. 21: 21–34.
16. GIANNOBILE, W.V., S.E. LYNCH, R.G. DENMARK, D.W. PAQUETTE, J.P. FIORELLINI &
R.C. WILLIAMS. 1995. Crevicular fluid osteocalcin and pyridinoline cross-linked
carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turn-
over in periodontitis. J. Clin. Periodontol. 22: 904–910.
17. SHIBUTANI, T., Y. MURAHASHI, E. TSUKADA, Y. IWAYAMA & J.N.M. HEERSCHE. 1997.
Experimentally induced periodontitis in beagle dogs causes rapid increases in osteo-
clastic resorption of alveolar bone. J. Periodontol. 68: 385–391.
18. SOCRANSKY, S.S., A.D. HAFFAJEE, M.A. CUGINI, C. SMITH & R.L. KENT JR. 1998.
Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134–144.
19. PALYS, M.D., A.D. HAFFAJEE, S.S. SOCRANSKY & W.V. GIANNOBILE. 1998. Relation-
ship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal
pathogens in periodontitis. J. Clin. Periodontol. 25: 865–871.
20. FIORELLINI, J.P., G. MARTUSCELLI & H.P. WEBER. 1998. Longitudinal studies on
implant systems. Periodontology 2000 17: 125–131.
21. ORINGER, R.J., M.D. PALYS, A. IRANMANESH, J.P. FIORELLINI, A.D. HAFFAJEE,
S.S. SOCRANSKY & W.V. GIANNOBILE. 1998. C-telopeptide pyridinoline cross-links
(ICTP) and periodontal pathogens associated with endosseous oral implants. Clin.
Oral Implants Res. 9: 365–373.
22. RYAN, M.E., S. RAMAMURTHY & L.M. GOLUB. 1996. Matrix metalloproteinases and
their inhibition in periodontal treatment. Curr. Opinion Periodontol. 3: 85–96.
23. WEINBERG, M.A. & M. BRAL. 1998. Tetracycline and its analogues: A therapeutic par-
adigm in periodontal diseases. Crit. Rev. Oral Biol. Med. 9: 322–332.
24. GOLUB, L. M., H.M. LEE, R.A. GREENWALD, M.E. RYAN, T. SORSA, T. SALO &
W.V. GIANNOBILE. 1997. A matrix metalloproteinase inhibitor reduces bone-type
collagen degradation fragments and specific collagenases in gingival crevicular fluid
during adult periodontitis. Inflamm. Res. 46: 310–319.
